Report: The Dutch Cancer Agenda (The Netherlands) - Revision history

Lucas: Update categories.

2025-12-14T12:10:41Z

Update categories.

← Older revision		Revision as of 12:10, 14 December 2025
Line 129:		Line 129:
	<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>		<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
	<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>		<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
			<span style="display:none">Head</span>
			<span style="display:none">Neck</span>
			<span style="display:none">Oral</span>
			<span style="display:none">Oral cavity</span>
			<span style="display:none">Pharynx</span>
			<span style="display:none">Pharyngeal</span>
			<span style="display:none">Tongue</span>
			<span style="display:none">Lingual</span>
			<span style="display:none">Nasal cavity</span>
			<span style="display:none">Nasal</span>
			<span style="display:none">Sinonasal</span>
			<span style="display:none">Sinus</span>
			<span style="display:none">Sinuses</span>
			<span style="display:none">Paranasal sinuses</span>
			<span style="display:none">Ear</span>
			<span style="display:none">Mandible</span>
			<span style="display:none">Maxilla</span>
			<span style="display:none">Jaw</span>
			<span style="display:none">Esophageal</span>
			<span style="display:none">Gastric</span>
			<span style="display:none">Intestinal</span>
			<span style="display:none">Bowel</span>
			<span style="display:none">Colorectal</span>
			<span style="display:none">Appendix</span>
			<span style="display:none">Appendiceal</span>
			<span style="display:none">Duodenum</span>
			<span style="display:none">Jejunum</span>
			<span style="display:none">Ileum</span>
			<span style="display:none">Anal</span>
			<span style="display:none">Perianal</span>
			<span style="display:none">Hepatic</span>
			<span style="display:none">Biliary</span>
			<span style="display:none">Hepatobiliary</span>
			<span style="display:none">Pulmonary</span>
			<span style="display:none">Thorax</span>
			<span style="display:none">Thoracic</span>
			<span style="display:none">Chest</span>
			<span style="display:none">Mediastinal</span>
			<span style="display:none">Pleural</span>
			<span style="display:none">Cutaneous</span>
			<span style="display:none">Dermal</span>
			<span style="display:none">Epidermal</span>
			<span style="display:none">Subcutaneous</span>
			<span style="display:none">Skeletal</span>
			<span style="display:none">Osseous</span>
			<span style="display:none">Chondral</span>
			<span style="display:none">Extremity</span>
			<span style="display:none">Axilla</span>
			<span style="display:none">Axillary</span>
			<span style="display:none">Mammary</span>
			<span style="display:none">Cervical</span>
			<span style="display:none">Uterine</span>
			<span style="display:none">Endometrial</span>
			<span style="display:none">Ovarian</span>
			<span style="display:none">Tubal</span>
			<span style="display:none">Fallopian</span>
			<span style="display:none">Vaginal</span>
			<span style="display:none">Vulvar</span>
			<span style="display:none">Adnexal</span>
			<span style="display:none">Renal</span>
			<span style="display:none">Urothelial</span>
			<span style="display:none">Ureteral</span>
			<span style="display:none">Urethral</span>
			<span style="display:none">Prostatic</span>
			<span style="display:none">Testicular</span>
			<span style="display:none">Penile</span>
			<span style="display:none">Ocular</span>
			<span style="display:none">Orbital</span>
			<span style="display:none">Retinal</span>
			<span style="display:none">Optic nerve</span>
			<span style="display:none">Meninges</span>
			<span style="display:none">Meningeal</span>
			<span style="display:none">Cerebral</span>
			<span style="display:none">Cerebellar</span>
			<span style="display:none">Brainstem</span>
			<span style="display:none">Lymphatic</span>
			<span style="display:none">Lymphoid</span>
			<span style="display:none">Lymphoma</span>
			<span style="display:none">Hematologic</span>
			<span style="display:none">Hematopoietic</span>
			<span style="display:none">Myeloma</span>
			<span style="display:none">Plasma cell</span>
			<span style="display:none">Diaphragm</span>
			<span style="display:none">Peripheral nerve</span>
			<span style="display:none">Heart</span>
			<span style="display:none">Cardiac</span>
			<span style="display:none">Endocrine</span>

Lucas: Update categories.

2025-12-10T19:16:29Z

Update categories.

← Older revision		Revision as of 19:16, 10 December 2025
Line 111:		Line 111:
	<span style="display:none">availableVariable::healthcare costs</span>		<span style="display:none">availableVariable::healthcare costs</span>
	<span style="display:none">dataLevel::national level</span>		<span style="display:none">dataLevel::national level</span>
			<span style="display:none">isReport</span>
	<span style="display:none">hasCancerType::C00-C97: All cancer types</span>		<span style="display:none">hasCancerType::C00-C97: All cancer types</span>
	~~<span style="display:none">isReport</span>~~
	<span style="display:none">hasCancerType::C00-D48: All neoplasms</span>		<span style="display:none">hasCancerType::C00-D48: All neoplasms</span>
	<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>		<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
Line 129:		Line 129:
	<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>		<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
	<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>		<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
	~~<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>~~
	~~<span style="display:none">hasCancerType::D10-D36: Benign tumour</span>~~
	~~<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>~~
	~~<span style="display:none">hasCancerType::unknown</span>~~

Lucas: Update categories.

2025-12-06T12:18:09Z

Update categories.

← Older revision		Revision as of 12:18, 6 December 2025
Line 129:		Line 129:
	<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>		<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
	<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>		<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
			<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
			<span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
			<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
			<span style="display:none">hasCancerType::unknown</span>

Lucas: Update categories.

2025-12-06T11:29:21Z

Update categories.

← Older revision		Revision as of 11:29, 6 December 2025
Line 113:		Line 113:
	<span style="display:none">hasCancerType::C00-C97: All cancer types</span>		<span style="display:none">hasCancerType::C00-C97: All cancer types</span>
	<span style="display:none">isReport</span>		<span style="display:none">isReport</span>
			<span style="display:none">hasCancerType::C00-D48: All neoplasms</span>
			<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
			<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span>
			<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span>
			<span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
			<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
			<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
			<span style="display:none">hasCancerType::C50: Breast cancer</span>
			<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
			<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
			<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
			<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
			<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
			<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
			<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
			<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>

Larysse at 17:46, 4 December 2025

2025-12-04T17:46:39Z

← Older revision		Revision as of 17:46, 4 December 2025
Line 1:		Line 1:
	<span style="display:none">forpolicymakers</span>		<span style="display:none">forpolicymakers</span>
			<span style="display:none">thenetherlandscountry</span>
	Go back to [[The Netherlands]] page		Go back to [[The Netherlands]] page

Lucas: Update categories.

2025-12-03T16:59:55Z

Update categories.

← Older revision		Revision as of 16:59, 3 December 2025
Line 111:		Line 111:
	<span style="display:none">dataLevel::national level</span>		<span style="display:none">dataLevel::national level</span>
	<span style="display:none">hasCancerType::C00-C97: All cancer types</span>		<span style="display:none">hasCancerType::C00-C97: All cancer types</span>
			<span style="display:none">isReport</span>

Lucas: Update categories.

2025-12-02T13:50:03Z

Update categories.

Show changes

Lara at 11:43, 12 September 2024

2024-09-12T11:43:53Z

← Older revision		Revision as of 11:43, 12 September 2024
Line 13:		Line 13:

	'''Access to information:''' [https://www.iccp-portal.org/system/files/plans/De-Nederlandse-Kanker-Agenda-1.0.pdf Click here to access].		'''Access to information:''' [https://www.iccp-portal.org/system/files/plans/De-Nederlandse-Kanker-Agenda-1.0.pdf Click here to access].

			{{Mouth}}
			{{Throat}}
			{{Oropharynx}}
			{{Nasopharynx}}
			{{Hypopharynx}}
			{{Larynx}}
			{{Salivary glands}}
			{{Lips}}
			{{Tonsils}}
			{{base of tongue}}
			{{Voice box}}
			{{Esophagus}}
			{{Stomach}}
			{{Small intestine}}
			{{Large intestine}}
			{{Colon}}
			{{Rectum}}
			{{Anus}}
			{{Liver}}
			{{Gallbladder}}
			{{Bile ducts}}
			{{Pancreas}}
			{{Lung}}
			{{Trachea}}
			{{Bronchi}}
			{{Pleura}}
			{{Mediastinum}}
			{{Bone}}
			{{Cartilage}}
			{{Osteosarcoma}}
			{{Ewings sarcoma}}
			{{Skin}}
			{{Melanoma}}
			{{Scalp}}
			{{Lips}}
			{{Hands}}
			{{Feet}}
			{{Muscle}}
			{{Fat}}
			{{Tendon}}
			{{Ligament}}
			{{Blood vessels}}
			{{Connective tissue}}
			{{Sarcoma}}
			{{Angiosarcoma}}
			{{Liposarcoma}}
			{{Lobular}}
			{{Breast}}
			{{Nipple}}
			{{Areola}}
			{{Ductal}}
			{{Vulva}}
			{{Vagina}}
			{{Cervix}}
			{{Uterus}}
			{{Ovary}}
			{{Fallopian tubes}}
			{{Endometrium}}
			{{Prostate}}
			{{Testicles}}
			{{Penis}}
			{{Kidney}}
			{{Ureter}}
			{{Bladder}}
			{{Urethra}}
			{{Eye}}
			{{Brain}}
			{{Spinal cord}}
			{{Thyroid gland}}
			{{Parathyroid}}
			{{Adrenal glands}}
			{{Pituitary gland}}
			{{Pancreas}}
			{{Thymus gland}}
			{{Peritoneum}}
			{{Pericardium}}
			{{Retroperitoneum}}
			{{Mesothelium}}
			{{Blood}}
			{{Bone marrow}}
			{{Lymph nodes}}
			{{Spleen}}
			{{Leukemia}}

Francine: Created page with "{{forpolicymakers}} Go back to The Netherlands page '''Primary purpose:''' To reduce the impact of cancer on society by establishing a set of 20 ambitious goals, focusing on prevention, improving quality of life, and enhancing treatment options for those affected before, during, and after cancer. '''Sponsor, manager or home institution:''' dataOwner::Dutch Cancer Collective (NKC). '''Type of information:''' Contains twenty specific goals aimed at reducing the..."

2024-07-05T17:13:44Z

Created page with "{{forpolicymakers}} Go back to The Netherlands page '''Primary purpose:''' To reduce the impact of cancer on society by establishing a set of 20 ambitious goals, focusing on prevention, improving quality of life, and enhancing treatment options for those affected before, during, and after cancer. '''Sponsor, manager or home institution:''' dataOwner::Dutch Cancer Collective (NKC). '''Type of information:''' Contains twenty specific goals aimed at reducing the..."

New page

{{forpolicymakers}}
Go back to [[The Netherlands]] page

'''Primary purpose:''' To reduce the impact of cancer on society by establishing a set of 20 ambitious goals, focusing on prevention, improving quality of life, and enhancing treatment options for those affected before, during, and after cancer.

'''Sponsor, manager or home institution:''' [[dataOwner::Dutch Cancer Collective (NKC)]].

'''Type of information:''' Contains twenty specific goals aimed at reducing the impact of cancer, focusing on prevention, treatment, and improving quality of life. It also outlines collaborative efforts, including the integration of various initiatives and the involvement of multiple stakeholders such as patient organizations, healthcare providers, and research institutions to achieve these goals. [[availableVariable::quality of life]], [[availableVariable::screening]], [[availableVariable::smoking habit]], [[availableVariable::alcohol consumption]], [[availableVariable::palliative care]], [[availableVariable::cancer incidence]], [[availableVariable::cancer survival]], [[availableVariable::diagnosis]], [[availableVariable::number of deaths]], [[availableVariable::causes of death]], [[availableVariable::healthcare costs]]. [https://www.iccp-portal.org/system/files/plans/De-Nederlandse-Kanker-Agenda-1.0.pdf Click here to learn more].

'''Data level''': [[dataLevel::national level]].

'''Cancer Areas of Interest''': [[hasCancerType::C00-C97: All cancer types]]. [https://www.iccp-portal.org/system/files/plans/De-Nederlandse-Kanker-Agenda-1.0.pdf Click here to learn more].

'''Access to information:''' [https://www.iccp-portal.org/system/files/plans/De-Nederlandse-Kanker-Agenda-1.0.pdf Click here to access].